J M Vigouret - JoVE Visualize

Showing results (11-20 of 14) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 14 results.

Journal of Medicinal Chemistry|June 1, 1986

Structure-activity relationships of dopaminergic 5-hydroxy-2-aminotetralin derivatives with functionalized N-alkyl substituentsM P Seiler, A P Stoll, A Closse, et al.

Life Sciences|January 13, 1986

Pharmacological profile of the abeorphine 201-678, a potent orally active and long lasting dopamine agonistA L Jaton, R K Giger, J M Vigouret, et al.

Neurology|June 1, 1989

Cognitive slowing in Parkinson's disease fails to respond to levodopa treatment: the 15-objects testB Pillon, B Dubois, A M Bonnet, et al.

Journal of Medicinal Chemistry|February 7, 1992

Centrally acting alpha 1-adrenoceptor agonists based on hexahydronaphth[2,3-b]-1,4-oxazines and octahydrobenzo[g]quinolinesJ Nozulak, J M Vigouret, A L Jaton, et al.

Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 14 results.

Journal of Medicinal Chemistry|June 1, 1986

Structure-activity relationships of dopaminergic 5-hydroxy-2-aminotetralin derivatives with functionalized N-alkyl substituentsM P Seiler, A P Stoll, A Closse, et al.

Life Sciences|January 13, 1986

Pharmacological profile of the abeorphine 201-678, a potent orally active and long lasting dopamine agonistA L Jaton, R K Giger, J M Vigouret, et al.

Neurology|June 1, 1989

Cognitive slowing in Parkinson's disease fails to respond to levodopa treatment: the 15-objects testB Pillon, B Dubois, A M Bonnet, et al.

Journal of Medicinal Chemistry|February 7, 1992

Centrally acting alpha 1-adrenoceptor agonists based on hexahydronaphth[2,3-b]-1,4-oxazines and octahydrobenzo[g]quinolinesJ Nozulak, J M Vigouret, A L Jaton, et al.

Pageof 2